Skip to main content

Table 2 Bleeding characteristics and treatments administered to the 15 patients

From: Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review

Parameter

Value

Site of bleeding

  

   Venoarterial ECMO

  

Mediastinal (post-surgery)

11 (73.3)

   Venovenous ECMO

  

Mediastinal (post-surgery)

1

Hemothorax

1

Gynecologic

1

Epistaxis

1

Transfusion required

  

   Packed red blood cell

17 (13.5-19)

   Fresh-frozen plasma

14 (9-21.5)

   Concentrated platelets

5 (3-8)

Biologic parameters before and after rFVIIa infusion

Before

After

   Hemoglobin

7.5 (7.1-8.6)

9 (8.2-9.8)

   Platelets

83 (61-117)

68 (61-106)

   PT

46 (42-52)

101 (54-120)

   aPTT

1.7 (1.4-2.2)

1.4 (1.2-1.9)

   Ionized calcemia

1.10 (1.05-1.20)

1.17 (1.03-1.28)

   pH

7.37 (7.28-7.42)

7.41 (7.34-7.47)

Temperature before rFVIIa infusion (°C)

36.4 (34.3-37.1)

rFVIIa dose infused (μg/kg)

77 (54-144)

Number of injections of rFVIIa, number of patients

  

   1

10

   2

3

   3

1

   4

1

  1. Data are expressed as number (%) or medians (IQR). aPTT, activated thromboplastin time; ECMO, extracorporeal membrane oxygenation; PT, prothrombin time; rFVIIA, recombinant factor VIIa.